[HTML][HTML] Application of radiomics and machine learning in head and neck cancers
With the continuous development of medical image informatics technology, more and more
high-throughput quantitative data could be extracted from digital medical images, which has …
high-throughput quantitative data could be extracted from digital medical images, which has …
[HTML][HTML] The usefulness of pretreatment MR-based radiomics on early response of neoadjuvant chemotherapy in patients with locally advanced nasopharyngeal …
P Yongfeng, J Chuner, W Lei, Y Fengqin… - Oncology …, 2021 - ncbi.nlm.nih.gov
The aim of this study was to explore the predictive role of pretreatment MRI-based radiomics
on early response of neoadjuvant chemotherapy (NAC) in locoregionally advanced …
on early response of neoadjuvant chemotherapy (NAC) in locoregionally advanced …
Role of long non-coding RNA in chemoradiotherapy resistance of nasopharyngeal carcinoma
Y Yang, QP Yuan, W Tang, Y Ma, JY Duan… - Frontiers in …, 2024 - frontiersin.org
Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the
nasopharyngeal epithelial cells. Common treatment methods for NPC include radiotherapy …
nasopharyngeal epithelial cells. Common treatment methods for NPC include radiotherapy …
Develo** a nomogram model and prognostic analysis of nasopharyngeal squamous cell carcinoma patients: a population-based study
K Liu, J Wang - Journal of Cancer Research and Clinical Oncology, 2023 - Springer
Background Nasopharyngeal squamous cell carcinoma (NPSCC) is a common histo-logical
subtype of nasopharyngeal cancer with a generally poor prognosis. The aim of this study is …
subtype of nasopharyngeal cancer with a generally poor prognosis. The aim of this study is …
The relationship of vascular endothelial growth factor and osteopontin expression with 3-year progression-free survival of locally advanced nasopharyngeal cancer …
Results The 3-year PFS obtained was 39%, with a median of 23 months. Vascular
endothelial growth factor expression was detected in 113 of 155 samples (72.9%), while …
endothelial growth factor expression was detected in 113 of 155 samples (72.9%), while …
Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review
L Yan, B Ren, R Hu, H Zhang, H Gou - Frontiers in Pharmacology, 2023 - frontiersin.org
Objective: For metastatic/recurrent nasopharyngeal carcinoma (NPC) patients, a
programmed cell death protein 1 (PD-1) is a controversial option. This meta-analysis aimed …
programmed cell death protein 1 (PD-1) is a controversial option. This meta-analysis aimed …
Intratumoral habitat radiomics based on magnetic resonance imaging for preoperative prediction treatment response to neoadjuvant chemotherapy in nasopharyngeal …
Y Zhu, D Zheng, S Xu, J Chen, L Wen, Z Zhang… - Japanese Journal of …, 2024 - Springer
Purpose The aim of this study is to determine intratumoral habitat regions from multi-
sequences magnetic resonance imaging (MRI) and to assess the value of those regions for …
sequences magnetic resonance imaging (MRI) and to assess the value of those regions for …
Prognostic value of circulating Epstein-Barr virus DNA level post-induction chemotherapy for patients with nasopharyngeal carcinoma: A recursive partitioning risk …
FF Kong, GS Pan, CR Du, MS Ni, RP Zhai… - Radiotherapy and …, 2023 - Elsevier
Background To evaluate the prognostic value of plasma Epstein-Barr virus (EBV) DNA level
post-induction chemotherapy (IC) for patients with nasopharyngeal carcinoma (NPC) …
post-induction chemotherapy (IC) for patients with nasopharyngeal carcinoma (NPC) …
Long noncoding RNA OIP5‐AS1 promotes the disease progression in nasopharyngeal carcinoma by targeting miR‐203
J Tang, C Fu, Y Li, S Chen, X Jiang… - BioMed Research …, 2021 - Wiley Online Library
Nasopharyngeal carcinoma (NPC) is a kind of malignancy generated from the
nasopharyngeal epithelium. Recently, long noncoding RNA (lncRNA) has been shown to be …
nasopharyngeal epithelium. Recently, long noncoding RNA (lncRNA) has been shown to be …
Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments
SM Jayawickrama, PM Ranaweera… - Cancer …, 2024 - Wiley Online Library
Background Precision healthcare has entered a new era because of the developments in
personalized medicine, especially in the diagnosis and treatment of head and neck …
personalized medicine, especially in the diagnosis and treatment of head and neck …